Publications

The publication of research results is a fundamental requirement for improving treatment concepts across the board. iOMEDICO supports the international guidelines on transparency and publication of medical research results.

We regularly present our data at national and international conferences. Our publications appear in scientifically renowned, international journals. Authors are principal investigators, investigators with a high number of participating patients, and iOMEDICO scientists.

TITEL
STUDIE
JAHR
Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC).

Schimanski, C.C., Kasper, S., Hegewisch-Becker, S., Schröder, J., Overkamp, F., Kullmann, F., Bechstein, W.O., Vöhringer, M., Öllinger, R., Lordick, F., Heinemann, V., Geißler, M., Schulz-Abelius, A., Bernhard, H., Schön, M.R., Greil, R., Galle, P., Lang, H., Schmidtmann, I., Moehler, M., 2020.

Oncoimmunology 9, 1806680.

Abstract

Indikation: Colorectal Cancer, Kolorektalkarzinom / Veranstaltung: - / Journal: Oncoimmunology
LICC
2020
Everolimus after failure of one prior VEGF‐targeted therapy in metastatic renal cell carcinoma: Final results of the MARC‐2 trial

Staehler M, Stöckle M, Christoph D C, Stenzl A, Potthoff K, Grimm M O, Klein D, Harde J, Brüning F, Goebell P J, Augustin M, Roos F, Benz-Rüd I, Marschner N, Grünwald V, 2020

Int J Cancer, 2020

Abstract

Indikation: Urogenital Tumors, Urogenitale Tumore / Veranstaltung: - / Journal: International Journal of Cancer
MARC-2
2020
First results from INFINITY – A Registry on Decision Making and Clinical Impact of Biomarker-Driven Precision Oncology in Routine Clinical Practice

U Martens, M Reiser, S Schirrmacher-Memmel, L Sellmann, T Decker, A Schneeweiss, M Schuler, F Bengsch, C Vannier, K Potthoff, N Marschner, B Kasenda, 2020

Oncol Res Treat. 2020;43(suppl 4)(247):251

Indikation: Präzisionsonkologie, Precision Oncology / Veranstaltung: DGHO / Journal: Oncology Research and Treatment
INFINITY
2020
Prophylaxis of chemotherapy-induced neutropenia with Lipegfilgrastim in patients with SCLC: final results from the non-interventional study NADIR

Losem C, Maintz C, Schulz H, Lück A, Geßner C, Grebhardt S, et al.

Oncol Res Treat. 2020;43(suppl 4)(200):328

Indikation: Lung Cancer, Lungenkarzinom / Veranstaltung: DGHO / Journal: Oncology Research and Treatment
NADIR
2020
Prophylaxis of chemotherapy-induced neutropenia with Lipegfilgrastim in patients with NSCLC: Final results from the non-interventional study NADIR

C Geßner, A Lück, H Schulz, C Losem, G Dresemann, S Grebhardt, J Harde, N Marschner, J Hipp, K Potthoff, 2020

Oncol Res Treat. 2020;43(suppl 4)(200):327

Indikation: Lung Cancer, Lungenkarzinom / Veranstaltung: DGHO / Journal: Oncology Research and Treatment
NADIR
2020
Treatment and outcome of a real-world cohort of patients with advanced, non-squamous NSCLC and KRAS mutations – Special focus on KRAS G12C

Griesinger F, Eberhardt WEE, Hoffnecht P, Metzenmacher M, Wehler T, Kokowski K, Alt J, Schütte W, Jänicke M, Fleitz A, Zacharias S, Hipper A, Buller M, Weichert W, Groschek M, von der Heyde E, Rauh J, Dechow T, Sebastian M, Thomas M, 2020

Oncol Res Treat. 2020;43 (suppl 4)(239):135

Indikation: Lung Cancer, Lungenkarzinom / Veranstaltung: DGHO / Journal: Oncology Research and Treatment
CRISP
2020
Wie beeinflusst die SarsCov2-Epidemie die Behandlung von Patienten mit Lungenkrebs in Deutschland? Daten aus der prospektiven CRISP Registerplattform

Griesinger F, Sebastian M, Fleitz A, Hipper A, Buller M, Jänicke M, Eberhardt WEE, Thomas M, 2020

Oncol Res Treat. 2020;43(suppl 4)(567):137

Indikation: Lung Cancer, Lungenkarzinom / Veranstaltung: DGHO / Journal: Oncology Research and Treatment
CRISP
2020
Die SarsCov2-Pandemie und Patienten mit (metastasierten) Krebserkrankungen in Deutschland – Daten aus vier prospektiven Registerplattformen

Marschner N, Spring L, Kruggel L, Henning H, Koska M, Binninger A, Frank M, Jänicke M, 2020

Oncol Res Treat. 2020;43 (suppl 4)(569):261

 

Indikation: Other, Sonstige / Veranstaltung: DGHO / Journal: Oncology Research and Treatment
Registerübergreifend
2020
Neuer Prognosescore und vergleichende Analyse der Erstlinientherapien mittels IPTW – Daten aus dem klinischen Tumorregister Pankreaskarzinom (TPK)

S Hegewisch-Becker, M Reiser, E von der Heyde, M Bertram, S Hollerbach, S Kreher, A Binninger, M Chiabudini, M Jänicke, N Marschner, 2020

Oncol Res Treat. 2020;43(suppl 4)(200):213

Indikation: Pancreatic Cancer, Pankreaskarzinom / Veranstaltung: DGHO / Journal: Oncology Research and Treatment
TPK
2020
Lebensqualität und Überleben von Patienten mit metastasiertem kolorektalem Karzinom in Deutschland – Daten aus dem klinischen Tumorregister Kolorektales Karzinom (TKK)

Uhlig J, Sauer A, Eggers E, Hahn L, Bernhardt C, Jänicke M, Spring L, Wetzel N, Marschner N, 2020

Oncol Res Treat. 2020;43(suppl 4)(182):127

Indikation: Colorectal Cancer, Kolorektalkarzinom / Veranstaltung: DGHO / Journal: Oncology Research and Treatment
TKK
2020